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1. INTRODUCTION 
Insulin and glucocorticoids probably both con- 
trol hepatic triacylglycerol synthesis (but in differ- 
ent ways). Insulin is known to stimulate the syn- 
thesis of fatty acids de novo and their subsequent 
conversion to tiracylglycerols in the liver. This in- 
crease in esteritication would also be favoured by 
the increase in the supply of glycerol 3-phosphate 
and dihydroxyacetone phosphate, and by an in- 
crease in the relative concentration of malo- 
nyl-CoA, an inhibitor of pamitoyl carnitine acyl- 
transferase (EC 2.3.1.21). The latter event would 
redirect acyl-CoA esters to the various acyltransfer- 
ases of glycerolipid synthesis, and hence promote 
esterification [l]. Furthermore, insulin may en- 
hance esterilication by increasing the mitochondrial 
glycerol 3-phosphate acyltransferase (EC 2.3.1.15) 
activity. However, the glycerol phosphate acyl- 
transferase of the endoplasmic reticulum, which is 
situated at the major site of hepatic triacylglycerol 
synthesis, is unaltered [2,3]. 
High concentrations of circulating glucocorti- 
coids also stimulate hepatic triacylglycerol synthesis 
in some situations in which fatty acids are being 
released by adipose tissue [4]. The major effect [5] of 
glucocorticoids on the enzymes of hepatic triacyl- 
glycerol synthesis is the increase in the activity of 
phosphatidate phosphohydrolase (EC 3.1.3.4). This 
stimulation can be directly demonstrated with iso- 
lated perfused livers [6], or with hepatocytes 171. 
The increased capacity of phosphatidate phospho- 
hydrolase facilitates the production of triacylgly- 
cerol, especially when the supply of substrates is 
high and the production of phosphatidate isnot rate- 
limiting [4]. 
Since both insulin and corticosterone stimulate 
hepatic triacylglycerol synthesis independently we 
investigated whether these hormones interact in 
controlling the activity of phosphatidate phospho- 
hydrolase in isolated hepatocytes. Alone, insulin 
produced a very small decrease (8%) in phosphati- 
date phosphohydrolase activity. However, in the 
presence of corticosterone, the stimulation of 
phosphatidate phosphohydrolase activity was pro- 
gressively inhibited by increasing concentrations of 
insulin. The inhibition was observed only if insulin 
was included at the beginning of the incubation; no 
effect was observed if the insulin was added 330 min 
after exposure to corticosterone. 
2. MATERIALS AND METHODS 
2.1. Materials 
Most of the materials employed have been des- 
cribed in [7]. The bovine insulin was a gift specially 
prepared and purified by the Boots Co. (Notting- 
ham). The potency of the insulin was 25-26 U/mg. 
Glucagon, vasoactive intestinal peptide and 
somatostatin were not detected in the sample whilst 
the pro-insulin content was < 0.5%. 
2.2. Preparation and incubation of hepatocytes and 
determination ofenzyme activities 
The methods for preparing and incubating hepa- 
tocytes, and for the determination of phosphati- 
date phosphohydrolase activity have been described 
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[7]. The latter activity was expressed relative to 
that of lactate dehydrogenase which was measured 
as in [8]. This was done to compensate for cell 
breakage. 
There was no consistent effect of insulin, or cor- 
ticosterone on the recovery of lactate dehydroge- 
nase in the hepatocytes after incubation, and cell 
breakage was normally < 5%. The metabolic via- 
bility of the cells was established by their high ATP 
contents and by the ability of glucocorticoids to 
stimulate the synthesis of phosphatidate phospho- 
hydrolase [ 71. 
3. RESULTS AND DISCUSSION 
As expected from [7], the incubation of hepato- 
cytes with corticosterone for 6 h increased the acti- 
vity of phosphatidate phosphohydrolase and maxi- 
mum stimulations were obtained over 10 - 6- 
10 - 5 M (tig.1). Corticosterone levels that are en- 
countered in vivo in these rats are 10 -‘-3 x 
10e6 M [5,9,10]. The addition of 20 mU insulin 
/ml to the incubations decreases the stimulating 
effects of corticosterone at 10 -’ -10 -4 M (fig. 1; 
table 1). The effect of 10 -5 M corticosterone was 
abolished when insulin was increased to IO-100 
mu/ml (fig.2). If insulin was added to the incuba- 
tions at 330 min, rather than at the beginning, it did 
not significantly modify the ability of corticosterone 
to increase the phosphohydrolase activity (table 1). 
Thus insulin probably inhibits the known effects of 
glucocorticoids in stimulating the synthesis of 
phosphatidate phosphohydrolase [6,7]. When insulin 
alone was added to the incubations there was a 
very small decrease in the activity of phosphatidate 
phosphohydrolase which was statistically signiti- 
cant (fig. 1, table 1). This may result from the inhibi- 
tion of phsophohydrolase synthesis which is stimu- 
lated by endogenous corticosterone in the hepa- 
tocytes. 
Initially the insulin antagonism of the corticoster- 
one-induced stimulation of phosphatidate phos- 
phohydrolase activity seems incongruous because 
both hormones are involved in stimulating triacyl- 
glycerol synthesis in the liver. However, several 
examples of this particular antagonism have been 
found in vivo. 
(1) The raised concentrations of circulating cor- 
ticosterone associated with the acute feeding of 
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Fig.]. Effect of corticosterone on the activity of phos- 
phatidate phosphohydrolase in hepatocytes incubated 
for 6 h in the presence of 20 mU insulin/ml (o), or in its 
absence (0). 
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Fig.2. Effect of insulin on the activity of phosphatidate 
phosphohydrolase in hepatocytes incubated for 6 h in 
the presence of 10 -5 M corticosterone (e), or in its 
absence (0). 
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Table I 
Effects of insulin and corticosterone on the activity of phosphatidate phosphohydrolase in isolated 
rat hepatocytes 
Additions Incubation Relative activity (5%) of Sig. diff.a 
time (min) phosphatidate 
phosphohydrolase 
I None 
II Corticosterone ( lop5 M) 
III Insulin (20 mu/ml) 
IV Corticosterone ( lop5 M) + 
insulin (20 mu/ml) 
V Corticosterone ( lop5 M) + 
insulin (20 mu/ml after 330 min) 
360 lOO(13) 
360 184 f 26(13) 
360 92 + 9 (11) 
360 121 f 23(11) 
360 198 + 64 (3) 
I vs II, P <O.OOl 
I vs III, P <0.05 
I vs IV, P <0.02 
II vs IV, P <O.OOl 
II vs V, n.s. 
a Calculated by using a paired r-test 
Results are shown as means + SD (no. independent expt) and are expressed relative to the activity 
when no hormone was added. The value of this control was 1.39 k 0.48 nmol diacylglycerol 
produced . min - I . U lactate dehydrogenase -I for the 13 independent expt. 
fructose, sorbitol, glycerol or ethanol [9,10] produ- 
ced an increase in hepatic phosphatidate phospho- 
hydrolase activity [ 10,111. However, the acute feed- 
ing of glucose to rats maintained on a standard 
laboratory diet raised insulin concentrations in 
concert with the increased corticosterone concen- 
trations 191, and it did not affect the activity of 
phosphatidate phosphohydrolase in the liver [ 111. 
Rats that were fed on semi-purified diets which 
were rich in starch or laid did show an increase in 
the phosphohydrolase activity after glucose feeding 
[IO]. Their corticosterone responses were much 
more pronounced, but their insulin responses were 
similar to the rats fed on the standard diet [lo]. 
(2) The circulating concentrations of corticoster- 
one in rats normally reach a peak 2 h before the 
beginning of the dark period of the daylight cycle 
[ 121. At this time the insulin concentrations are re- 
latively low. These conditions favour the synthesis 
of the phosphohydrolase which reaches a peak ac- 
tivity 2 h after dark [12]. This is the time when the 
rats are feeding so that insulin concentrations rise, 
whereas those of corticosterone fall. There should 
be no immediate effect on the phosphohydrolase 
activity (table l), but its rate of synthesis should 
decrease and the activity should subsequently de- 
cline [ 121. 
(3) High phosphatidate phosphohydrolase acti- 
vities in the liver are characteristic of a variety of 
conditions in which the importance of glucocorti- 
coids relative to insulin in controlling metabolism is 
increased (41. The high phosphohydrolase activities 
that are observed in the livers of rats with ketotic 
diabetes are decreased by insulin therapy [ 13,141. 
It is still not entirely clear why insulin should 
antagonise the glucocorticoid-induced increase in 
the phosphohydrolase activity. However, it should 
be remembered that insulin in vivo would also in- 
hibit the release of fatty acids from adipose tissue 
and their supply to the liver. The glucocorti- 
coid-induced increase of the phosphohydrolase acti- 
vity probably enables the liver to partially main- 
tain its production of diacylglycerol when the syn- 
thesis of phosphatidate declines because of low 
insulin concentrations and when substrate avail- 
ability is restricted. This would help to preserve the 
synthesis of phosphatidylcholine and phosphatidyl- 
ethanolamine which are required for membrane 
turnover and for bile production. If the substrate 
supply is high then the increased phosphohydrolase 
activity facilitates the synthesis of triacylglycerols. 
These triacylglycerols may accumulate to produce a 
fatty liver, or they may be secreted as very low 
density lipoprotein. In the latter case the fatty acids 
11 
Volume 143, number 1 FEBS LETTERS June 1982 
are subsequently taken up by heart and skeletal 
muscle in which the lipoprotein lipase activity is 
maintained by glucocorticoids rather than by insu- 
lin [4]. 
Insulin also antagonises the effects of glucocorti- 
coids in stimulating: 
(i) The synthesis of phsophatidylcholine in cells 
cultured from foetal lung [ 151; 
(ii) The activity of argininosuccinate synthetase 
and argininosuccinate lyase [ 161; 
(iii) The activity of phosphoenolpyruvate carboxy- 
kinase in Reuber H35 cells [ 17,181; 
(iv) The activity of tryptophan oxygenase in rat 
hepatocytes [ 191; 
(v) The activity of tyrosine aminotransferase in 
foetal hepatocytes [20]. 
By contrast, insulin and glucocorticoids can prod- 
uce additive stimulations in the activity of tyrosine 
aminotransferase in Reuber H35 cells [ 17,181. 
In a number of the examples given above the 
antagonistic interactions of insulin and glucocorti- 
coids seem to be related to the function of the liver 
in exporting energy in periods of metabolic stress. 
For instance, the brain is receiving ketones and 
glucose, and heart and skeletal muscle are being 
supplied with ketones and triacylglycerols. One of 
the functions of the glucocorticoid-induced stimu- 
lations of phosphatidate phosphohydrolase may be 
to redirect fatty acids towards muscle tissue in these 
conditions. 
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